Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands.
Penumbra, Inc.
Unlock to Claim this listing
Add / Modify Company
3.2
Overall Excellence Rating
Industry
HealthcareCategory
Medical Instruments & SuppliesESG/Ethical Impact
Penumbra’s environmental impact extends to its operations and product lifecycle. By adopting sustainable manufacturing practices, resource-efficient technologies, and eco-conscious packaging solutions, the company works to reduce its ecological footprint. This may involve the use of biocompatible materials, energy-efficient processes, and a commitment to waste reduction, ultimately contributing to more sustainable medical device production and distribution.For Penumbra, social impact revolves around the potential benefits its medical devices bring to patients and healthcare systems. Ensuring the safety, effectiveness, and accessibility of its products is central. Additionally, the company may focus on fostering innovation that addresses critical medical needs, thus enhancing patient outcomes and contributing to advancements in medical care that positively impact societies. Penumbra’s commitment to employee well-being is evident in its approach to creating a supportive work environment. By providing professional growth opportunities, fostering a culture of diversity and inclusion, and prioritizing employee health and safety, the company demonstrates its dedication to the holistic well-being of its workforce.Strong governance and ethical practices are paramount in the medical device industry, and Penumbra often adheres to rigorous regulatory standards. Transparent communication about product safety, clinical validation, and ethical marketing is essential. Upholding ethical conduct in research, patient care, and regulatory compliance underscores the company’s commitment to governance and ethical responsibility.Penumbra’s financial sustainability is intertwined with its dedication to innovation. The company allocates substantial resources to research and development initiatives, enabling the creation of cutting-edge medical technologies that address unmet medical needs. By investing in groundbreaking research, Penumbra nurtures a pipeline of innovative products that have the potential to drive revenue growth and solidify its position as a market leader. Penumbra’s financial strength empowers it to pursue strategic expansion into new markets and regions. This calculated approach to market diversification not only enhances revenue streams but also positions the company to impact more lives with its medical devices. By expanding its footprint while maintaining financial prudence, Penumbra sets the stage for sustained growth and value generation.Penumbra’s commitment to ethical innovation underscores its dedication to patient well-being. The company places patient safety and clinical efficacy at the forefront of its product development efforts, ensuring that medical devices meet the highest standards of quality and ethical practice. Transparent communication about product capabilities and limitations reinforces Penumbra’s commitment to responsible medical advancements.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us

Awards Received
2023
Revenues
$847,100,000.00
Website Traffic
Employee Rating
3.3
Customer Rating
3.5
Company Size
1000-5000
ESG Risk Rating
3